Mast cells and type I interferon responses in the skin of patients with juvenile dermatomyositis: Are current therapies just scratching the surface?
Open Access
- 21 April 2010
- journal article
- editorial
- Published by Wiley in Arthritis & Rheumatism
- Vol. 62 (9), 2619-2622
- https://doi.org/10.1002/art.27525
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Long‐term outcome and prognostic factors of juvenile dermatomyositis: A multinational, multicenter study of 490 patientsArthritis Care & Research, 2009
- The inflammatory milieu in idiopathic inflammatory myositisCurrent Rheumatology Reports, 2009
- Mast cells and histamine metabolism in skin lesions from MRL/MP-lpr/lpr miceAutoimmunity Reviews, 2009
- Photoessay of the cutaneous manifestations of the idiopathic inflammatory myopathiesDermatology Online Journal, 2009
- Persistent association of nailfold capillaroscopy changes and skin involvement over thirty‐six months with duration of untreated disease in patients with juvenile dermatomyositisArthritis & Rheumatism, 2008
- The Cutaneous Assessment Tool: development and reliability in juvenile idiopathic inflammatory myopathyRheumatology, 2007
- Plasmacytoid dendritic cells in inflamed muscle of patients with juvenile dermatomyositisArthritis & Rheumatism, 2007
- History of infection before the onset of juvenile dermatomyositis: Results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Research RegistryArthritis Care & Research, 2005
- Mast Cells: A Cellular Link Between Autoantibodies and Inflammatory ArthritisScience, 2002
- Mast cells in neuromuscular diseasesJournal of the Neurological Sciences, 1990